Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06083545
Other study ID # ting652520
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date July 15, 2023
Est. completion date July 20, 2025

Study information

Verified date October 2023
Source Tri-Service General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The effects of Application intervention on the physiological indicators and low protein diet cognition among the patients with chronic kidney disease


Description:

The low-protein diet app introduces the perceived significant efficacy of low-protein diets for patients with chronic kidney disease.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 184
Est. completion date July 20, 2025
Est. primary completion date July 20, 2025
Accepts healthy volunteers No
Gender All
Age group 20 Years to 85 Years
Eligibility Inclusion Criteria: - Aged 20 years or above and agree to participate in the research - Conscious, literate and able to communicate in Mandarin and Taiwanese - Have the ability to use vehicles - Kidney disease stage is 3b as calculated by the MDRD formula From stage 5 to stage 5, he has not yet received alternative therapy and is diagnosed as a patient with chronic kidney disease by a nephrologist. Exclusion Criteria: - Blindness - Cognitive abnormalities diagnosed by a doctor as dementia or mental disorder - People who have no ability to act independently and are assisted by others in daily life - Patients with nephrotic syndrome are excluded.

Study Design


Intervention

Behavioral:
App
The low-protein diet app introduces the perceived significant efficacy of low-protein diets for patients with chronic kidney disease.

Locations

Country Name City State
Taiwan Tri-Services General Hospital Taipei Neihu

Sponsors (1)

Lead Sponsor Collaborator
yi ting Hsu

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary basic information Gender, age, education level, living status, financial resources, employment status, time of suffering from kidney disease, stage of kidney disease, time of nephrology treatment, combined chronic diseases, number of health education sessions by health teachers and nutritionists. 2 years
Primary physiological index It is an index for regular tracking and testing of research subjects. Information is provided by the laboratory department of the hospital of the research subjects. It mainly tracks serum potassium, phosphorus, sodium, calcium, and eGFR. 2 years
Primary ow protein diet awareness scale This scale was developed with reference to the Chronic Kidney Disease Health Management Manual of the Ministry of Health and Welfare (2018), with a total of 7 questions. It is scored as "true", "wrong" and "don't know", calculated on a scale of 0 to 1, with the highest It is 7 points, with forward and reverse questions. The higher the score, the more correct the understanding of low-protein diet. 2 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03596749 - The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4 Phase 3
Not yet recruiting NCT05514184 - Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease N/A
Recruiting NCT03415074 - Could Ketoanalogue-supplemented Low Protein Diet Defer Dialysis in Advanced Diabetic Kidney Disease? (K-DDD) N/A
Not yet recruiting NCT04102319 - Serum Hepcidin, Haemoglobin Level and Iron Status in Chronic Kidney Disease Patients (CKD) With Anaemia
Recruiting NCT05309785 - Safety and Efficacy of Canagliflozin in Advanced CKD Phase 4
Not yet recruiting NCT06094920 - Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial Phase 4
Completed NCT05705011 - Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.
Completed NCT03588884 - Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency Phase 4
Recruiting NCT05508009 - Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor Phase 1/Phase 2
Recruiting NCT04633304 - A Single Arm sTudy to Evaluate the Effectiveness of EndoAVF in a Pre-dialysis Population (STEP Study) N/A
Completed NCT04862715 - The Iron and Muscle Study Phase 4